Sunday, March 1, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025

    The cost structure of hospitals nearly doubles

    July 1, 2025
    Navigating the Medical Licensing Maze

    The Fight Against Healthcare Fraud: Dr. Rafai’s Story

    April 8, 2025
  • Surveys

    Surveys

    How Confident Are You in RFK Jr.’s Health Leadership?

    How Confident Are You in RFK Jr.’s Health Leadership?

    February 16, 2026
    AI in Healthcare Decision-Making

    AI in Healthcare Decision-Making

    February 1, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025

    The cost structure of hospitals nearly doubles

    July 1, 2025
    Navigating the Medical Licensing Maze

    The Fight Against Healthcare Fraud: Dr. Rafai’s Story

    April 8, 2025
  • Surveys

    Surveys

    How Confident Are You in RFK Jr.’s Health Leadership?

    How Confident Are You in RFK Jr.’s Health Leadership?

    February 16, 2026
    AI in Healthcare Decision-Making

    AI in Healthcare Decision-Making

    February 1, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Uncertainty & Complexity

Racism Affects Neuroanatomy

Racism promotes health inequities.

Negar Fani by Negar Fani
December 20, 2023
in Uncertainty & Complexity
0
Racism Affects Neuroanatomy

Planet Volumes

The U.S. is in the midst of a racial reckoning. The COVID-19 pandemic, which took a particularly heavy toll on Black communities, turned a harsh spotlight on long-standing health disparities that the public could no longer overlook.

Although the health disparities for Black communities have been well known to researchers for decades, the pandemic put real names and faces to these numbers. Compared with white people, Black people are at much greater risk for developing a range of health problems, including heart disease, diabetes and dementia. For example, Black people are twice as likely as white people to develop Alzheimer’s disease.

A vast and growing body of research shows that racism contributes to systems that promote health inequities. Most recently, our team has also learned that racism directly contributes to these inequities on a neurobiological level.

We are clinical neuroscientists who study the multifaceted ways in which racism affects how our brains develop and function. We use brain imaging to study how trauma such as sexual assault or racial discrimination can cause stress that leads to mental health disorders like depression and post-traumatic stress disorder, or PTSD.

We have studied trauma in the context of a study known as the Grady Trauma Project, which has been running for nearly 20 years. This study is largely focused on the trauma and stress of Black people in the metropolitan Atlanta, Georgia, community.

How discrimination alters the brain

Racial discrimination is commonly experienced through subtle indignities: a woman clutching her purse as a Black man walks by on the sidewalk, a shopkeeper keeping close watch on a Black woman shopping in a clothing store, a comment about a Black employee being a “diversity hire.” These slights are often referred to as microaggressions.

Decades of research has shown that the everyday burden of these race-related threats, slights and exclusions in day-to-day life translates into a real increase in disease risk. But researchers are only beginning to understand how these forms of discrimination affect a person’s biology and overall health.

Our team’s research shows that the everyday burden of racism affects the function and structure of the brain. In turn, these changes play a major role in risk for health problems.

For instance, our studies show that racial discrimination increases the activity of brain regions, such as the prefrontal cortex, that are involved in regulating emotions.

Scientist and technologist view brain images.
Negar Fani and a team member view brain images.
Patrick Heagney

This increased activity in prefrontal brain regions occurs because responding to these types of affronts requires high-effort coping strategies, such as suppressing emotions. People who have experienced more racial discrimination also show more activation in brain regions that enable them to inhibit and suppress anger, shock or sadness so that they can curate a socially acceptable response.

A cost for overcompensating

Despite the fact that high-energy coping allows people to manage a constant barrage of threats, this comes at a cost.

The more brain energy you use to suppress, control or manage your feelings, the more energy you take away from the rest of the body. Over time, and without prolonged periods of rest, relief and restoration, this can contribute to other problems, a process that public health researcher Arline Geronimus termed “weathering.” Having these brain regions in continual overdrive is linked with accelerated biological aging, which can create vulnerability for health problems and early death.

In our research, we have found that this weathering process is evident in the gradual degradation of brain structure, particularly in the heavily myelinated axons of the brain, known as “white matter,” which serve as the brain’s information highways.

Computer-generated image of white matter tracts in the brain.
Rendering of white matter fibers − shown in color − throughout the brain.
Negar Fani

Myelin is a protective sheath around nerve fibers that allows for improved communication between brain cells. Similar to highways for vehicles, without sufficient maintenance of the myelin, degradation will occur.

Erosion in these brain pathways can affect self-regulation, making a person more vulnerable to developing unhealthy coping strategies for stress, such as emotional eating or substance use. These behaviors, in turn, can increase one’s risk for a wide variety of health problems.

These racism-related changes in the brain, and their direct effects on coping, may help to explain why Black people are twice as likely to develop brain health problems such as Alzheimer’s disease compared with white people.

Recognizing racial gaslighting

In our view, what makes racism particularly insidious and pernicious to the health of Black people is the societal invalidation that accompanies it. This makes racial trauma effectively invisible. Racism, whether it originates from people or from institutional systems, is often rationalized, excused or dismissed.

Such invalidation leads those who experience racism to second-guess themselves: “Am I just being too sensitive?” People who have the temerity to report racist events are often ridiculed or met with skepticism. This extends to academic spheres as well.

This continual questioning and doubting of the circumstances around racist experiences, or racial gaslighting, may be part of what depletes the brain of its resources, causing the weathering that ultimately increases vulnerability to brain health problems.

Interrupting this cycle requires that people learn to identify their biases toward people of color and people in marginalized groups more generally, and to understand how those biases may lead to discriminatory words and behavior. We believe that by finding their blind spots, people can see ways in which their actions and behaviors could be viewed as hurtful, exclusionary or offensive. Through recognition of these experiences as racist, people can become allies rather than skeptics.

Institutions can help to create a culture of healing, validation and support for people of color. A validating, supportive institutional culture may help people of color normalize their reactions to these stressors, in addition to the connection – and restoration – they may find within their communities.

Negar Fani, Associate Professor of Psychiatry and Neuroscience, Emory University and Nathaniel Harnett, Assistant Professor of Psychiatry, Harvard Medical School

This article is republished from The Conversation under a Creative Commons license. Read the original article.

ShareTweet
Negar Fani

Negar Fani

Associate Professor of Psychiatry and Neuroscience, Emory University

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

This conversation focuses on debunking myths surrounding GLP-1 medications, particularly the misinformation about their association with pancreatic cancer. The speaker emphasizes the importance of understanding clinical study designs, especially the distinction between observational studies and randomized controlled trials. The discussion highlights the need for patients to critically evaluate the sources of information regarding medication side effects and to empower themselves in their healthcare decisions.

Takeaways
GLP-1 medications are not linked to pancreatic cancer.
Peer-reviewed studies debunk misinformation about GLP-1s.
Anecdotal evidence is not reliable for general conclusions.
Observational studies have limitations in generalizability.
Understanding study design is crucial for evaluating claims.
Symptoms should be discussed in the context of clinical conditions.
Not all side effects reported are relevant to every patient.
Observational studies can provide valuable insights but are context-specific.
Patients should critically assess the relevance of studies to their own experiences.
Engagement in discussions about specific studies can enhance understanding

Chapters
00:00
Debunking GLP-1 Medication Myths
02:56
Understanding Clinical Study Designs
05:54
The Role of Observational Studies in Healthcare
Debunking Myths About GLP-1 Medications
YouTube Video DM9Do_V6_sU
Subscribe

2027 Medicare Advantage & Part D Advance Notice

Clinical Reads

BIIB080 in Mild Alzheimer’s Disease: What a Phase 1b Exploratory Clinical Analysis Can—and Cannot—Tell Us

BIIB080 in Mild Alzheimer’s Disease: What a Phase 1b Exploratory Clinical Analysis Can—and Cannot—Tell Us

by Daily Remedy
February 15, 2026
0

Can lowering tau biology translate into a clinically meaningful slowing of decline in people with early symptomatic Alzheimer’s disease? That is the practical question behind BIIB080, an intrathecal antisense therapy designed to reduce production of tau protein by targeting the tau gene transcript. In a phase 1b program originally designed for safety and dosing, investigators later examined cognitive, functional, and global outcomes as exploratory endpoints. The clinical question matters because current disease-modifying options primarily target amyloid, while tau pathology tracks...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • When Health Records Become Hostage: The Rise of Espionage in Healthcare Data Breaches

    When Health Records Become Hostage: The Rise of Espionage in Healthcare Data Breaches

    1 shares
    Share 0 Tweet 0
  • Abortion’s Precedent

    0 shares
    Share 0 Tweet 0
  • The Great COVID Vaccine Bet

    0 shares
    Share 0 Tweet 0
  • The Healthcare Jungle

    0 shares
    Share 0 Tweet 0
  • Vaping: A Tale of Two Crises

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy